Geriatric

Altered liver function markers appeared associated with Alzheimer’s disease diagnosis and impaired memory and executive function, as well as amyloid-, tau and neurodegenerative biomarkers of Alzheimer’s pathophysiology, according to study results published in JAMA Network Open.

In patients aged 75 years of age or older taking statins for primary CVD prevention, discontinuing statin therapy was associated with a 33% increased risk for hospital admission for a CV event, researchers reported.